Europe At-Home Testing Kits Market - Industry Trends and Forecast to 2029

TABLE OF CONTENT

TABLE OF CONTENTS
1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.3 OVERVIEW OF EUROPE AT-HOME TESTING KITS MARKET 33
1.4 LIMITATIONS 35
1.5 MARKETS COVERED 35
2 MARKET SEGMENTATION 38
2.1 MARKETS COVERED 38
2.2 GEOGRAPHICAL SCOPE 39
2.3 YEARS CONSIDERED FOR THE STUDY 40
2.4 CURRENCY AND PRICING 40
2.5 DBMR TRIPOD DATA VALIDATION MODEL 41
2.6 MULTIVARIATE MODELLING 44
2.7 EUROPE AT-HOME TESTING KITS MARKET, BY TEST TYPE 44
2.8 MARKET POSITION COVERAGE GRID 45
2.9 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 46
2.10 DBMR MARKET POSITION GRID 47
2.11 DISTRIBUTOR CHANNEL ANALYSIS 48
2.12 SECONDARY SOURCES 49
2.13 ASSUMPTIONS 49
3 EXECUTIVE SUMMARY 50
4 PREMIUM INSIGHTS 53
4.1 PESTEL ANALYSIS 55
4.2 PORTER'S FIVE FORCES 56
5 EUROPE AT- HOME TESTING KITS MARKET: REGULATIONS 57
5.1 REGULATION IN U.S 57
5.2 GUIDELINES FOR SELF-TESTING KITS 57
5.3 REGULATION IN EUROPE 58
5.4 GUIDELINES FOR TESTING KITS 58
5.5 REGULATION IN INDONESIA: 58

6 MARKET OVERVIEW 60
6.1 DRIVERS 62
6.1.1 GROWING ADOPTION OF SELF-TESTING KITS 62
6.1.2 EASY AVAILABILITY OF SELF-TESTING KITS AT PHARMACIES 62
6.1.3 INCREASE IN AWARENESS ABOUT THE IMPORTANCE OF HIV DIAGNOSIS 62
6.1.4 EASE OF USE AND LOW COSTS OF RAPID SELF-TEST KITS 63
6.2 RESTRAINTS 63
6.2.1 INACCURACY OF RESULTS BY SELF-TESTING KITS 63
6.2.2 STRINGENT GOVERNMENT REGULATIONS FOR MANUFACTURING AND DISTRIBUTION OF TESTING KITS 64
6.3 OPPORTUNITIES 65
6.3.1 ADVENT OF ADVANCED TECHNOLOGIES 65
6.3.2 EMERGING NEED FOR RAPID TESTING KITS FOR COVID-19 PANDEMIC 65
6.3.3 STRATEGIC INITIATIVES OF KEY PLAYERS 66
6.4 CHALLENGES 66
6.4.1 HIGH COMPETITION IN THE MEDICAL TECHNOLOGY INDUSTRY 66
6.4.2 REDUCTION IN RESEARCH & DEVELOPMENT BUDGETS 67
7 EUROPE AT-HOME TESTING KITS MARKET, BY TEST TYPE 68
7.1 OVERVIEW 69
7.2 GLUCOSE TESTS 72
7.3 INFECTIOUS DISEASES 72
7.4 PREGNANCY TEST 73
7.5 DRUG ABUSE TEST KITS 74
7.6 HIV TEST KIT 75
7.7 OVULATION PREDICTOR TEST KIT 76
7.8 OTHERS TEST TYPES 76
8 EUROPE AT-HOME TESTING KITS MARKET, BY TYPE 78
8.1 OVERVIEW 79
8.2 CASSETTES 82
8.2.1 RETAIL PHARMACIES 83
8.2.2 ONLINE PHARMACIES 83
8.2.3 DRUG STORE 83
8.2.4 SUPERMARKET/HYPERMARKET 83
8.3 STRIP 83
8.3.1 RETAIL PHARMACIES 84
8.3.2 ONLINE PHARMACIES 84
8.3.3 DRUG STORE 84
8.3.4 SUPERMARKET/HYPERMARKET 84
8.4 MIDSTREAM 84
8.4.1 RETAIL PHARMACIES 85
8.4.2 ONLINE PHARMACIES 85
8.4.3 DRUG STORE 85
8.4.4 SUPERMARKET/HYPERMARKET 85
8.5 DIP CARD 86
8.5.1 RETAIL PHARMACIES 86
8.5.2 ONLINE PHARMACIES 87
8.5.3 DRUG STORE 87
8.5.4 SUPERMARKET/HYPERMARKET 87
8.6 TEST PANEL 87
8.6.1 RETAIL PHARMACIES 88
8.6.2 ONLINE PHARMACIES 88
8.6.3 DRUG STORE 88
8.6.4 SUPERMARKET/HYPERMARKET 88
8.7 OTHERS 88
9 EUROPE AT-HOME TESTING KITS MARKET, BY AGE 90
9.1 OVERVIEW 91
9.2 ADULT 94
9.3 GERIATRIC 94
9.4 PEDIATRIC 95
10 EUROPE AT-HOME TESTING KITS MARKET, BY SAMPLE TYPE 96
10.1 OVERVIEW 97
10.2 BLOOD 100
10.3 URINE 100
10.4 SALIVA 101
10.5 OTHER SAMPLE TYPES 101
11 EUROPE AT-HOME TESTING KITS MARKET, BY USAGE 103
11.1 OVERVIEW 104
11.2 DISPOSABLE 107
11.3 REUSABLE 107
12 EUROPE AT-HOME TESTING KITS MARKET, BY DISTRIBUTION CHANNELS 109
12.1 OVERVIEW 110
12.2 RETAIL PHARMACIES 113
12.3 ONLINE PHARMACIES 113
12.4 DRUG STORE 114
12.5 SUPERMARKET/HYPERMARKET 114
13 EUROPE AT-HOME TESTING KITS MARKET, BY REGION 116
13.1 EUROPE 117
13.1.1 GERMANY 124
13.1.2 U.K. 127
13.1.3 FRANCE 130
13.1.4 ITALY 133
13.1.5 SPAIN 136
13.1.6 NETHERLANDS 139
13.1.7 SWITZERLAND 142
13.1.8 RUSSIA 145
13.1.9 TURKEY 148
13.1.10 BELGIUM 151
13.1.11 REST OF EUROPE 154
14 EUROPE AT-HOME TESTING KITS MARKET: COMPANY LANDSCAPE 155
14.1 COMPANY SHARE ANALYSIS: EUROPE 155
15 SWOT ANALYSIS 156
16 COMPANY PROFILE 157
16.1 ABBOTT 157
16.1.1 COMPANY SNAPSHOT 157
16.1.2 REVENUS ANALYSIS 157
16.1.3 COMPANY SHARE ANALYSIS 158
16.1.4 PRODUCT PORTFOLIO 158
16.1.5 RECENT DEVELOPMENT 158
16.2 SIEMENS HEALTHCARE GMBH 159
16.2.1 COMPANY SNAPSHOT 159
16.2.2 REVENUS ANALYSIS 159
16.2.3 PRODUCT PORTFOLIO 160
16.2.4 RECENT DEVELOPMENTS 160
16.3 F. HOFFMANN- LA ROCHE LTD 161
16.3.1 COMPANY SNAPSHOT 161
16.3.2 REVENUE ANALYSIS 161
16.3.3 COMPANY SHARE ANALYSIS 162
16.3.4 PRODUCT PORTFOLIO 162
16.3.5 RECENT DEVELOPMENTS 162

16.4 BD 163
16.4.1 COMPANY SNAPSHOT 163
16.4.2 REVENUE ANALYSIS 163
16.4.3 PRODUCT PORTFOLIO 164
16.4.4 RECENT DEVELOPMENTS 164
16.5 DRGERWERK AG & CO. KGAA 165
16.5.1 COMPANY SNAPSHOT 165
16.5.2 REVENUE ANALYSIS 165
16.5.3 COMPANY SHARE ANALYSIS 166
16.5.4 PRODUCT PORTFOLIO 166
16.5.5 RECENT DEVELOPMENTS 166
16.6 LIFESCAN IP HOLDINGS, LLC 167
16.6.1 COMPANY SNAPSHOT 167
16.6.2 COMPANY SHARE ANALYSIS 167
16.6.3 PRODUCT PORTFOLIO 168
16.6.4 RECENT DEVELOPMENTS 168
16.7 ASCENSIA DIABETES CARE HOLDINGS AG. 169
16.7.1 COMPANY SNAPSHOT 169
16.7.2 COMPANY SHARE ANALYSIS 169
16.7.3 PRODUCT PORTFOLIO 170
16.7.4 RECENT DEVELOPMENTS 170
16.8 NECTAR LIFESCIENCES LTD. (RAPIKIT) 171
16.8.1 COMPANY SNAPSHOT 171
16.8.2 PRODUCT PORTFOLIO 171
16.8.3 RECENT DEVELOPMENTS 171
16.9 ACON LABORATORIES, INC. 172
16.9.1 COMPANY SNAPSHOT 172
16.9.2 PRODUCT PORTFOLIO 172
16.9.3 RECENT DEVELOPMENTS 172
16.10 QUIDEL CORPORATION. 173
16.10.1 COMPANY SNAPSHOT 173
16.10.2 REVENUE ANALYSIS 173
16.10.3 PRODUCT PORTFOLIO 174
16.10.4 RECENT DEVELOPMENTS 174
16.11 ARKRAY USA, INC. 175
16.11.1 COMPANY SNAPSHOT 175
16.11.2 PRODUCT PORTFOLIO 175
16.11.3 RECENT DEVELOPMENTS 175

16.12 BTNX INC. 176
16.12.1 COMPANY SNAPSHOT 176
16.12.2 PRODUCT PORTFOLIO 176
16.12.3 RECENT DEVELOPMENTS 176
16.13 ATOMO DIAGNOSTICS 177
16.13.1 COMPANY SNAPSHOT 177
16.13.2 REVENUE ANALYSIS 177
16.13.3 PRODUCT PORTFOLIO 178
16.13.4 RECENT DEVELOPMENTS 178
16.14 EUROFINS SCIENTIFIC 179
16.14.1 COMPANY SNAPSHOT 179
16.14.2 REVENUE ANALYSIS 179
16.14.3 PRODUCT PORTFOLIO 180
16.14.4 RECENT DEVELOPMENTS 180
16.15 PIRAMAL ENTERPRISES LTD. 181
16.15.1 COMPANY SNAPSHOT 181
16.15.2 REVENUE ANALYSIS 181
16.15.3 PRODUCT PORTFOLIO 182
16.15.4 RECENT DEVELOPMENTS 182
16.16 BIONIME CORPORATION 183
16.16.1 COMPANY SNAPSHOT 183
16.16.2 REVENUE ANALYSIS 183
16.16.3 PRODUCT PORTFOLIO 184
16.16.4 RECENT DEVELOPMENTS 184
16.17 NOVA BIOMEDICAL 185
16.17.1 COMPANY SNAPSHOT 185
16.17.2 PRODUCT PORTFOLIO 185
16.17.3 RECENT DEVELOPMENTS 185
16.18 CARDINAL HEALTH. 186
16.18.1 COMPANY SNAPSHOT 186
16.18.2 REVENUE ANALYSIS 186
16.18.3 PRODUCT PORTFOLIO 187
16.18.4 RECENT DEVELOPMENTS 187
16.19 ORASURE TECHNOLOGIES 188
16.19.1 COMPANY SNAPSHOT 188
16.19.2 REVENUE ANALYSIS 188
16.19.3 PRODUCT PORTFOLIO 189
16.19.4 RECENT DEVELOPMENTS 189

16.20 BIOLYTICAL LABORATORIES INC. 190
16.20.1 COMPANY SNAPSHOT 190
16.20.2 PRODUCT PORTFOLIO 190
16.20.3 RECENT DEVELOPMENTS 190
16.21 EVERLYWELL, INC. 191
16.21.1 COMPANY SNAPSHOT 191
16.21.2 PRODUCT PORTFOLIO 191
16.21.3 RECENT DEVELOPMENTS 191
16.22 SA SCIENTIFIC LTD. 192
16.22.1 COMPANY SNAPSHOT 192
16.22.2 PRODUCT PORTFOLIO 192
16.22.3 RECENT DEVELOPMENTS 192
16.23 CLEARBLUE (A SUBSIDIARY OF SWISS PRECISION DIAGNOSTICS GMBH) 193
16.23.1 COMPANY SNAPSHOT 193
16.23.2 PRODUCT PORTFOLIO 193
16.23.3 RECENT DEVELOPMENTS 193
16.24 BIOSYNEX 194
16.24.1 COMPANY SNAPSHOT 194
16.24.2 PRODUCT PORTFOLIO 194
16.24.3 RECENT DEVELOPMENTS 194
16.25 PRIMA LAB SA 195
16.25.1 COMPANY SNAPSHOT 195
16.25.2 PRODUCT PORTFOLIO 195
16.25.3 RECENT DEVELOPMENTS 196
16.26 MP BIOMEDICALS. 197
16.26.1 COMPANY SNAPSHOT 197
16.26.2 PRODUCT PORTFOLIO 197
16.26.3 RECENT DEVELOPMENTS 197
16.27 STERILAB SERVICES 198
16.27.1 COMPANY SNAPSHOT 198
16.27.2 PRODUCT PORTFOLIO 198
16.27.3 RECENT DEVELOPMENTS 198
16.28 CHEMBIO DIAGNOSTICS, INC. 199
16.28.1 COMPANY SNAPSHOT 199
16.28.2 REVENUE ANALYSIS 199
16.28.3 PRODUCT PORTFOLIO 200
16.28.4 RECENT DEVELOPMENTS 200

16.29 BIOSURE 201
16.29.1 COMPANY SNAPSHOT 201
16.29.2 PRODUCT PORTFOLIO 201
16.29.3 RECENT DEVELOPMENTS 201
16.30 SELFDIAGNOSTICS OU 202
16.30.1 COMPANY SNAPSHOT 202
16.30.2 PRODUCT PORTFOLIO 202
16.30.3 RECENT DEVELOPMENTS 202
17 QUESTIONNAIRE 203
18 RELATED REPORTS 206